Psoriasis Drugs Market to Thrive Due to Growing Number of Psoriasis Victims
The report "Psoriasis Drugs Market by Drug Type (Pharmaceuticals and Biopharmaceuticals), by Route of Administration (Topical and Systemic), by Target (Tumour Necrosis Factor, Phosphodiesterase Type 4, Interleukin, and Others), and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)" says, The Psoriasis Drugs market is expected to reach USD 10.8 Billion by 2021 from an estimated USD 7.6 Billion in 2016, at a CAGR of 7.3%.
View full press release